SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries informs about press release

23 Jul 2025 Evaluate

Sigachi Industries has informed that the company’s one of India’s leading players in pharmaceutical excipients, APIs, and specialty ingredients, is set to strengthen its scientific and technical capabilities with the commencement of operations at its newly established R&D Center in Hyderabad. Positioned as a critical pillar of the company’s innovation strategy, this R&D Center will drive end-to-end API development—from lab-scale innovation to commercialization and global regulatory filings. A press release to this extent is enclosed.

The above information is a part of company’s filings submitted to BSE. 

Sigachi Industries Share Price

22.67 -0.68 (-2.91%)
20-Apr-2026 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.50
Dr. Reddys Lab 1233.20
Cipla 1232.00
Zydus Lifesciences 937.70
Lupin 2327.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×